Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Regulus Therapeutics is a biopharmaceutical company specializing in discovering and developing microRNA-based therapeutics for diseases with high unmet medical needs. Its focus includes orphan kidney diseases like ADPKD, utilizing proprietary oligonucleotide technologies and extensive IP. The company advances drug candidates through preclinical and clinical stages, leveraging collaborations and a strong scientific platform to target complex diseases via gene regulation modulation.
This description was generated via AI from an annual report. Updated about 1 year ago.